Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01633684 · ClinicalTrials.gov registry record
Type 1 Diabetes Mellitus Effect on Bone Mineral Density
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 123
- Enrollment target
NCT01633684: Completed study, sponsored by Creighton University.
NCT01633684 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01633684 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
Because the diabetics are fracturing at a younger age than the general population (12), this leads us to believe there are significant factors that lead to fracture in Type 1 diabetes mellitus (DM) other than bone mineral density (BMD). Very little longitudinal data exists on BMD in adults with Type 1 DM and the effects of glucose control on BMD. No longitudinal data exists on pQCT in adults with Type 1 DM. Hypothesis: Adult subjects with diabetes and poor glucose control will lose bone mineral density (BMD) as measured by DXA compared to age and sex matched healthy controls.
Primary Outcome
Bone mineral density will be measured yearly for 5 years
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-07 |
What the finished NCT01633684 record still lists
NCT01633684 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01633684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01633684 about?
NCT01633684 is a clinical study titled "Type 1 Diabetes Mellitus Effect on Bone Mineral Density". Because the diabetics are fracturing at a younger age than the general population (12), this leads us to believe there are significant factors that lead to fracture in Type 1 diabetes mellitus (DM) other than bone mineral density (BMD). Very little longitudinal data exists on BMD in adults with Type...
What is the current status of trial NCT01633684?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2012-08. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT01633684?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia